Protection by a Fourth Dose of BNT162b2 against Omicron in Israel

BACKGROUND: On January 2, 2022, Israel began administering a fourth dose of BNT162b2 vaccine to persons 60 years of age or older. Data are needed regarding the effect of the fourth dose on rates of confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and of severe coronav...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar-On, Yinon M., Goldberg, Yair, Mandel, Micha, Bodenheimer, Omri, Amir, Ofra, Freedman, Laurence, Alroy-Preis, Sharon, Ash, Nachman, Huppert, Amit, Milo, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006780/
https://www.ncbi.nlm.nih.gov/pubmed/35381126
http://dx.doi.org/10.1056/NEJMoa2201570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006780/
https://www.ncbi.nlm.nih.gov/pubmed/35381126
http://dx.doi.org/10.1056/NEJMoa2201570

Ejemplares similares